Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases

Faciogenital dysplasia 5 (FGD5) amplification drives tumor cell proliferation, and is present in 9.5% of breast cancers. We describe FGD5 expression, assess associations between FGD5 amplification and FGD5 expression, and assess FGD5 expression in relation to proliferation and prognosis. FGD5 immuno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Histochem Cytochem
Autors principals: Valla, Marit, Mjønes, Patricia G., Engstrøm, Monica J., Ytterhus, Borgny, Bordin, Diana L., van Loon, Barbara, Akslen, Lars A., Vatten, Lars J., Opdahl, Signe, Bofin, Anna M.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6213565/
https://ncbi.nlm.nih.gov/pubmed/30052477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1369/0022155418792032
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars